Emerging role of GLP-1 agonists in cardio-metabolic therapy - Focus on Semaglutide

Emerging role of GLP-1 agonists in cardio-metabolic therapy - Focus on Semaglutide

Semaglutide, a GLP-1 receptor agonist, has emerged as a promising agent in cardiovascular disease management, particularly for patients with obesity and diabetes. Recent studies have demonstrated significant benefits of Semaglutide beyond glycemic control, including reduced major adverse cardiovascu...

Full description

Saved in:
Bibliographic Details
Main Authors: Celestine Odigwe, Rajasekhar Mulyala, Haijra Malik, Brent Ruiz, Mariam Riad, Mohammad As Sayiadeh, Sanchitha Honganur, Alexis Parks, Mustafeez Ur Rahman, Nasser Lakkis
Format: Article
Language:English
Published: Elsevier 2025-04-01
Series:American Heart Journal Plus
Subjects:
Glucagon-like peptide-1
Semaglutide
Atherosclerotic risk
Heart failure
Inflammation
Online Access:http://www.sciencedirect.com/science/article/pii/S2666602225000217
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2666602225000217

Similar Items